Notch signaling proteins: Legitimate targets for cancer therapy

Current Protein and Peptide Science

Volumn 11, Issue 6, 2010, Pages 398-408

  Wang, Zhiwei ^a   Li, Yiwei ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

And gamma; secretase inhibitors; Cancer; Cancer therapy; Natural agents; Notch; Oncogene; Review; Signal pathway

Indexed keywords

FLUOROURACIL; GAMMA SECRETASE INHIBITOR; GLUCOCORTICOID; NOTCH RECEPTOR; OXALIPLATIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER THERAPY; COLON CANCER; COLORECTAL CANCER; DRUG POTENTIATION; GASTROINTESTINAL TOXICITY; GLIOBLASTOMA; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; STOMACH CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; HUMANS; LIGANDS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN BINDING; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 78549290515     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920310791824039     Document Type: Article

References (107)

1. Miele, L.; Osborne, B. Arbiter of differentiation and death: Notchsignaling meets apoptosis. J. Cell, Physiol., 1999, 181, 393-409.
2. Miele, L. Notch signaling. Clin. Cancer Res., 2006, 12, 1074-1079.
3. Weinmaster, G. The ins and outs of notch signaling. Mol. Cell, Neurosci., 1997, 9, 91-102.
4. Kopan, R.; Ilagan, M. X. The canonical Notch signaling pathway:unfolding the activation mechanism. Cell, 2009, 137, 216-233.
5. Fortini, M. E. Notch signaling: the core pathway and its posttranslationalregulation. Dev. Cell, 2009, 16, 633-647.
6. Miele, L.; Miao, H.; Nickoloff, B. J. Notch signaling as a novelcancer therapeutic target. Curr. Cancer Drug Targets, 2006, 6,313-323.
7. Rizzo, P.; Osipo, C.; Foreman, K.; Golde, T.; Osborne, B.; Miele, L. Rational targeting of Notch signaling in cancer. Oncogene, 2008, 27, 5124-5131.
8. Wang, Z.; Li, Y.; Banerjee, S.; Sarkar, F. H. Exploitation of theNotch signaling pathway as a novel target for cancer therapy. Anti-Cancer Res., 2008, 28, 3621-3630.
9. Dotto, G. P. Notch tumor suppressor function. Oncogene, 2008, 27, 5115-5123.
10. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancerstatistics. CA Cancer J. Clin., 2009, 59, 225-249.
11. Buchler, P.; Gazdhar, A.; Schubert, M.; Giese, N.; Reber, H. A.; Hines, O. J.; Giese, T.; Ceyhan, G. O.; Muller, M.; Buchler, M. W.; Friess, H. The Notch signaling pathway is related to neurovascularprogression of pancreatic cancer. Ann. Surg., 2005, 242, 791-800.
12. Miyamoto, Y.; Maitra, A.; Ghosh, B.; Zechner, U.; Argani, P.; Iacobuzio-Donahue, C. A.; Sriuranpong, V.; Iso, T.; Meszoely, I. M.; Wolfe, M. S.; Hruban, R. H.; Ball, D. W.; Schmid, R. M.; Leach, S. D. Notch mediates TGF alpha-induced changes in epithelialdifferentiation during pancreatic tumorigenesis. Cancer Cell, 2003, 3, 565-576.
13. De La, O. J.; Emerson, L. L.; Goodman, J. L.; Froebe, S. C.; Illum, B. E.; Curtis, A. B.; Murtaugh, L. C. Notch and Kras reprogram pancreaticacinar cells to ductal intraepithelial neoplasia. Proc. Natl. Acad. Sci. USA, 2008, 105, 18907-18912.
14. De La, O. J.; Murtaugh, L. C. Notch and Kras in pancreatic cancer:at the crossroads of mutation, differentiation and signaling. Cell Cycle, 2009, 8, 1860-1864.
15. Kimura, K.; Satoh, K.; Kanno, A.; Hamada, S.; Hirota, M.; Endoh, M.; Masamune, A.; Shimosegawa, T. Activation of Notch signalingin tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracenein mice. Cancer Sci., 2007, 98, 155-162.
16. Mullendore, M. E.; Koorstra, J. B.; Li, Y. M.; Offerhaus, G. J.; Fan, X.; Henderson, C. M.; Matsui, W.; Eberhart, C. G.; Maitra, A.; Feldmann, G. Ligand-dependent Notch signaling is involved in tumorinitiation and tumor maintenance in pancreatic cancer. Clin. Cancer Res., 2009, 15, 2291-2301.
17. Sawey, E. T.; Johnson, J. A.; Crawford, H. C. Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc. Natl. Acad. Sci. USA, 2007, 104, 19327-19332.
18. Wang, Z.; Banerjee, S.; Li, Y.; Rahman, K. M.; Zhang, Y.; Sarkar, F. H. Down-regulation of Notch-1 inhibits invasion by inactivationof nuclear factor-{kappa}B, vascular endothelial growth factor, andmatrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res., 2006, 66, 2778-2784.
19. Wang, Z.; Zhang, Y.; Li, Y.; Banerjee, S.; Liao, J.; Sarkar, F. H. Down-regulation of Notch-1 contributes to cell growth inhibitionand apoptosis in pancreatic cancer cells. Mol. Cancer Ther., 2006,5, 483-493.
20. Wang, Z.; Li, Y.; Kong, D.; Banerjee, S.; Ahmad, A.; Azmi, A. S. Ali, S.; Abbruzzese, J. L.; Gallick, G. E.; Sarkar, F. H. Acquisition ofepithelial-mesenchymal transition phenotype of gemcitabineresistantpancreatic cancer cells is linked with activation of thenotch signaling pathway. Cancer Res., 2009, 69, 2400-2407.
21. Ji, Q.; Hao, X.; Zhang, M.; Tang, W.; Yang, M.; Li, L.; Xiang, D.; Desano, J. T.; Bommer, G. T.; Fan, D.; Fearon, E. R.; Lawrence, T. S.; Xu, L. Micro RNA miR-34 inhibits human pancreatic cancertumor-initiating cells. PLo S One, 2009, 4, e6816.
22. Shou, J.; Ross, S.; Koeppen, H.; de, Sauvage, F. J.; Gao, W. Q. Dynamics of notch expression during murine prostate developmentand tumorigenesis. Cancer Res., 2001, 61, 7291-7297.
23. Bin, H. B.; Adhami, V. M.; Asim, M.; Siddiqui, I. A.; Bhat, K. M.; Zhong, W.; Saleem, M.; Din, M.; Setaluri, V.; Mukhtar, H. Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin. Cancer Res., 2009, 15, 452-459.
24. Villaronga, M. A.; Bevan, C. L.; Belandia, B. Notch signaling: apotential therapeutic target in prostate cancer. Curr. Cancer Drug Targets, 2008, 8, 566-580.
25. Leong, K. G.; Gao, W. Q. The Notch pathway in prostate developmentand cancer. Differentiation, 2008, 76, 699-716.
26. Zayzafoon, M.; Abdulkadir, S. A.; McDonald, J. M. Notch signalingand ERK activation are important for the osteomimetic propertiesof prostate cancer bone metastatic cell lines. J. Biol. Chem., 2004,279, 3662-3670.
27. Santagata, S.; Demichelis, F.; Riva, A.; Varambally, S.; Hofer, M. D.; Kutok, J. L.; Kim, R.; Tang, J.; Montie, J. E.; Chinnaiyan, A. M.; Rubin, M. A.; Aster, J. C. JAGGED1 expression is associatedwith prostate cancer metastasis and recurrence. Cancer Res., 2004,64, 6854-6857.
28. Zhang, Y.; Wang, Z.; Ahmed, F.; Banerjee, S.; Li, Y.; Sarkar, F. H. Down-regulation of Jagged-1 induces cell growth inhibition and Sphase arrest in prostate cancer cells. Int. J. Cancer, 2006, 119(9), 2071-2077.
29. Alimirah, F.; Panchanathan, R.; Davis F. J.; Chen, J.; Choubey, D. Restoration of p53 expression in human cancer cell lines upregulatesthe expression of Notch1: implications for cancer cell fate determinationafter genotoxic stress. Neoplasia, 2007, 9, 427-434.
30. Nantermet, P. V.; Xu, J.; Yu, Y.; Hodor, P.; Holder, D.; Adamski, S.; Gentile, M. A.; Kimmel, D. B.; Harada, S.; Gerhold, D.; Freedman, L. P.; Ray, W. J. Identification of genetic pathways activatedby the androgen receptor during the induction of proliferation in theventral prostate gland. J. Biol. Chem., 2004, 279, 1310-1322.
31. Belandia, B.; Powell, S. M.; Garcia-Pedrero, J. M.; Walker, M. M.; Bevan. C. L.; Parker. M. G.; Hey1, a mediator of notch signaling, isan androgen receptor corepressor. Mol. Cell Biol., 2005, 25, 1425-1436.
32. Wu, F.; Stutzman, A.; Mo, Y. Y. Notch signaling and its role inbreast cancer. Front Biosci., 2007, 12, 4370-4383.
33. Stylianou, S.; Clarke, R. B.; Brennan, K. Aberrant activation ofnotch signaling in human breast cancer. Cancer Res., 2006, 66, 1517-1525.
34. Reedijk, M.; Odorcic, S.; Chang, L.; Zhang, H.; Miller, N.; McCready, D. R.; Lockwood, G.; Egan, S. E. High-level coexpressionof JAG1 and NOTCH1 is observed in human breast cancerand is associated with poor overall survival. Cancer Res., 2005, 65, 8530-8537.
35. Mungamuri, S. K.; Yang, X.; Thor, A. D.; Somasundaram, K. Survivalsignaling by Notch1: mammalian target of rapamycin(mTOR)-dependent inhibition of p53. Cancer Res., 2006, 66, 4715-4724.
36. Lee, C. W.; Simin, K.; Liu, Q.; Plescia, J.; Guha, M.; Khan, A. Hsieh, C. C.; Altieri, D. C. A functional Notch-survivin gene signaturein basal breast cancer. Breast Cancer Res., 2008, 10, R97.
37. Rizzo, P.; Miao, H.; D'Souza, G.; Osipo, C.; Song, L. L.; Yun, J.; Zhao, H.; Mascarenhas, J.; Wyatt, D.; Antico, G.; Hao, L.; Yao, K.; Rajan, P.; Hicks, C.; Siziopikou, K.; Selvaggi, S.; Bashir, A.; Bhandari, D.; Marchese, A.; Lendahl, U.; Qin, J. Z.; Tonetti, D. A.; Albain, K.; Nickoloff, B. J.; Miele, L. Cross-talk between notch andthe estrogen receptor in breast cancer suggests novel therapeuticapproaches. Cancer Res., 2008, 68, 5226-5235.
38. Leong, K. G.; Niessen, K.; Kulic, I.; Raouf, A.; Eaves, C.; Pollet, I.; Karsan, A. Jagged1-mediated Notch activation induces epithelialto-mesenchymal transition through Slug-induced repression of Ecadherin. J. Exp. Med., 2007, 204, 2935-2948.
39. O'Neill, C. F.; Urs, S.; Cinelli, C.; Lincoln, A.; Nadeau, R. J.; Leon, R.; Toher, J.; Mouta-Bellum, C.; Friesel, R. E.; Liaw, L. Notch2signaling induces apoptosis and inhibits human MDA-MB-231xenograft growth. Am. J. Pathol., 2007, 171, 1023-1036.
40. Yamaguchi, N.; Oyama, T.; Ito, E.; Satoh H.; Azuma, S.; Hayashi, M.; Shimizu, K.; Honma, R.; Yanagisawa, Y.; Nishikawa, A.; Kawamura, M.; Imai, J; Ohwada, S.; Tatsuta, K,.; Inoue, J.; Semba, K.; Watanabe, S. NOTCH3 signaling pathway plays crucial roles inthe proliferation of Erb B2-negative human breast cancer cells. Cancer Res., 2008, 68, 1881-1888.
41. Phillips, T. M.; Kim, K.; Vlashi, E.; McBride, W. H.; Pajonk, F. Effects of recombinant erythropoietin on breast cancer-initiatingcells. Neoplasia, 2007, 9, 1122-1129.
42. Farnie, G.; Clarke, R. B. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev., 2007, 3, 169-175.
43. Collins, B. J.; Kleeberger, W.; Ball, D. W. Notch in lung developmentand lung cancer. Semin. Cancer Biol., 2004, 14, 357-364.
44. Sriuranpong, V.; Borges, M. W.; Ravi, R. K.; Arnold, D. R.; Nelkin, B. D.; Baylin, S. B.; Ball, D. W. Notch signaling induces cell cyclearrest in small cell lung cancer cells. Cancer Res., 2001, 61, 3200-3205.
45. Chen, H.; Thiagalingam, A.; Chopra, H.; Borges, M. W.; Feder, J. N.; Nelkin, B. D.; Baylin, S. B.; Ball, D. W. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc. Natl. Acad. Sci. USA, 1997, 94, 5355-5360.
46. Chen, Y.; De, Marco M. A.; Graziani, I.; Gazdar, A. F.; Strack, P. R.; Miele, L.; Bocchetta, M. Oxygen concentration determines the biologicaleffects of NOTCH-1 signaling in adenocarcinoma of thelung. Cancer Res., 2007, 67, 7954-7959.
47. Dang, T. P.; Eichenberger, S.; Gonzalez, A.; Olson, S.; Carbone, D. P. Constitutive activation of Notch3 inhibits terminal epithelialdifferentiation in lungs of transgenic mice. Oncogene, 2003, 22, 1988-1997.
48. Dang, T. P.; Gazdar, A. F.; Virmani, A. K.; Sepetavec, T.; Hande, K. R.; Minna, J. D.; Roberts, J. R.; Carbone, D. P. Chromosome 19translocation, overexpression of Notch3, and human lung cancer. J. Natl. Cancer Inst., 2000, 92, 1355-1357.
49. Konishi, J.; Kawaguchi, K. S.; Vo, H.; Haruki, N.; Gonzalez, A.; Carbone, D. P.; Dang, T. P. Gamma-secretase inhibitor preventsNotch3 activation and reduces proliferation in human lung cancers. Cancer Res., 2007, 67, 8051-8057.
50. Haruki, N.; Kawaguchi, K. S.; Eichenberger, S.; Massion, P. P.; Olson, S.; Gonzalez, A.; Carbone, D. P.; Dang, T. P. Dominantnegative Notch3 receptor inhibits mitogen-activated protein kinasepathway and the growth of human lung cancers. Cancer Res., 2005,65, 3555-3561.
51. Radtke, F.; Clevers, H. Self-renewal and cancer of the gut: twosides of a coin. Science, 2005, 307, 1904-1909.
52. Reedijk, M.; Odorcic, S.; Zhang, H.; Chetty, R.; Tennert, C.; Dickson, B. C.; Lockwood, G.; Gallinger, S.; Egan, S. E. Activationof Notch signaling in human colon adenocarcinoma. Int. J. Oncol., 2008, 33, 1223-1229.
53. Akiyoshi, T.; Nakamura, M.; Yanai, K.; Nagai, S.; Wada, J.; Koga, K.; Nakashima, H.; Sato, N.; Tanaka, M.; Katano, M. Gammasecretaseinhibitors enhance taxane-induced mitotic arrest andapoptosis in colon cancer cells. Gastroenterology, 2008, 134, 131-144.
54. Fre, S.; Pallavi, S. K.; Huyghe, M.; Lae, M.; Janssen, K. P.; Robine, S.; Rtavanis-Tsakonas, S.; Louvard, D. Notch and Wnt signals cooperativelycontrol cell proliferation and tumorigenesis in the intestine. Proc. Natl. Acad. Sci. USA, 2009, 106, 6309-6314.
55. Meng, R. D.; Shelton, C. C.; Li, Y. M; Qin, L. X.; Notterman, D.; Paty, P. B.; Schwartz, G. K. Gamma-Secretase inhibitors abrogateoxaliplatin-induced activation of the Notch-1 signaling pathway incolon cancer cells resulting in enhanced chemosensitivity. Cancer Res., 2009, 69, 573-582.
56. Ghaleb, A. M.; Aggarwal, G.; Bialkowska, A. B.; Nandan, M. O.; Yang, V. W. Notch inhibits expression of the Kruppel-like factor 4tumor suppressor in the intestinal epithelium. Mol. Cancer Res., 2008, 6, 1920-1927.
57. Sjolund, J.; Johansson, M.; Manna, S.; Norin, C.; Pietras, A.; Beckman, S.; Nilsson, E.; Ljungberg, B.; Axelson, H. Suppressionof renal cell carcinoma growth by inhibition of Notch signaling invitro and in vivo. J. Clin. Invest., 2008, 118, 217-228.
58. Patel, N. S.; Li, J. L.; Generali, D.; Poulsom, R.; Cranston, D. W.; Harris, A. L. Up-regulation of delta-like 4 ligand in human tumorvasculature and the role of basal expression in endothelial cellfunction. Cancer Res., 2005, 65, 8690-8697.
59. Sun, S.; Du, R.; Gao, J.; Ning, X.; Xie, H.; Lin, X.; Liu, J.; Fan, D. Expression and clinical significance of Notch receptors in humanrenal cell carcinoma. Pathology, 2009, 41, 335-341.
60. Qi, R.; An, H.; Yu, Y.; Zhang, M.; Liu, S.; Xu, H.; Guo, Z.; Cheng, T.; Cao, X. Notch1 signaling inhibits growth of human hepatocellularcarcinoma through induction of cell cycle arrest and apoptosis. Cancer Res., 2003, 63, 8323-8329.
61. Wang, C.; Qi, R.; Li, N.; Wang, Z.; An, H.; Zhang, Q.; Yu, Y.; Cao, X. Notch1 signaling sensitizes tumor necrosis factor-relatedapoptosis-inducing ligand-induced apoptosis in human hepatocellularcarcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradationand up-regulating p53-dependent DR5 expression. J. Biol. Chem., 2009, 284, 16183-16190.
62. Suwanjunee, S.; Wongchana, W.; Palaga, T. Inhibition of gammasecretaseaffects proliferation of leukemia and hepatoma cell linesthrough Notch signaling. Anticancer Drugs, 2008, 19, 477-486.
63. Giovannini, C.; Lacchini, M.; Gramantieri, L.; Chieco, P.; Bolondi, L. Notch3 intracellular domain accumulates in Hep G2 cell line. Anti Cancer Res., 2006, 26, 2123-2127.
64. Hainaud, P.; Contreres, J. O.; Villemain, A.; Liu, L. X.; Plouet, J.; Tobelem, G.; Dupuy, E. The role of the vascular endothelial growthfactor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vesselremodeling and endothelial cell functions. Cancer Res., 2006,66, 8501-8510.
65. Wang, M.; Xue, L.; Cao, Q.; Lin, Y.; Ding, Y.; Yang, P.; Che, L. Expression of Notch1, Jagged1 and beta-catenin and their clinicopathologicalsignificance in hepatocellular carcinoma. Neoplasma, 2009, 56, 533-541.
66. Gao, J.; Song, Z.; Chen, Y.; Xia, L.; Wang, J.; Fan, R.; Du, R.; Zhang, F.; Hong, L.; Song, J.; Zou, X.; Xu, H.; Zheng, G.; Liu, J.; Fan, D. Deregulated expression of Notch receptors in human hepatocellularcarcinoma. Dig. Liver Dis., 2008, 40, 114-121.
67. Gao, J.; Chen, C.; Hong, L.; Wang, J.; Du, Y.; Song, J.; Shao, X.; Zhang, J.; Han, H.; Liu, J.; Fan, D. Expression of Jagged1 and itsassociation with hepatitis B virus X protein in hepatocellular carcinoma. Biochem. Biophys. Res. Commun., 2007, 356, 341-347.
68. Gramantieri, L.; Giovannini, C.; Lanzi, A.; Chieco, P.; Ravaioli, M.; Venturi, A.; Grazi, G. L.; Bolondi, L. Aberrant Notch3 andNotch4 expression in human hepatocellular carcinoma. Liver Int., 2007, 27, 997-1007.
69. Cantarini, M. C.; de la Monte, S. M.; Pang, M.; Tong, M.; D'Errico, A.; Trevisani, F.; Wands, J. R. Aspartyl-asparagyl beta hydroxylaseover-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology, 2006, 44, 446-457.
70. Ellisen, L. W.; Bird, J.; West, D. C.; Soreng, A. L.; Reynolds, T. C.; Smith, S. D.; Sklar, J. TAN-1, the human homolog of the Drosophilanotch gene, is broken by chromosomal translocations in Tlymphoblastic neoplasms. Cell, 1991, 66, 649-661.
71. Demarest, R. M.; Ratti, F.; Capobianco, A. J. It's T-ALL aboutNotch. Oncogene, 2008, 27, 5082-5091.
72. Real, PJ.; Ferrando, A. A. Notch inhibition and glucocorticoid therapyin T-cell acute lymphoblastic leukemia. Leukemia, 2009, 23, 1374-1377.
73. Grabher, C.; von, B. H.; Look AT. Notch 1 activation in the molecularpathogenesis of T-cell acute lymphoblastic leukaemia. Nat. Rev. Cancer, 2006, 6, 347-359.
74. Jundt, F.; Schwarzer, R.; Dorken, B. Notch signaling in leukemiasand lymphomas. Curr. Mol. Med., 2008, 8, 51-59.
75. Shih, A. H.; Holland, E. C. Notch signaling enhances nestin expressionin gliomas. Neoplasia, 2006, 8, 1072-1082.
76. Kanamori, M.; Kawaguchi, T.; Nigro, J. M.; Feuerstein, B. G.; Berger, M. S.; Miele, L.; Pieper, R. O. Contribution of Notch signalingactivation to human glioblastoma multiforme. J. Neurosurg., 2007, 106, 417-427.
77. Hulleman, E.; Quarto, M.; Vernell, R.; Masserdotti, G.; Colli, E.; Kros, J. M.; Levi, D.; Gaetani, P.; Tunici, P.; Finocchiaro, G.; Baena, R. R.; Capra, M.; Helin, K. A role for the transcription factorHEY1 in glioblastoma. J. Cell Mol. Med., 2009, 13, 136-146.
78. Sivasankaran, B.; Degen, M.; Ghaffari, A.; Hegi, M. E.; Hamou, M. F.; Ionescu, M. C.; Zweifel, C.; Tolnay, M.; Wasner, M.; Mergenthaler, S.; Miserez, A. R.; Kiss, R.; Lino, M. M.; Merlo, A. Tenascin-C is a novel RBPJkappa-induced target gene for Notchsignaling in gliomas. Cancer Res., 2009, 69, 458-465.
79. Shiras, A.; Chettiar, S. T.; Shepal, V.; Rajendran, G.; Prasad, G. R.; Shastry, P. Spontaneous transformation of human adult nontumorigenicstem cells to cancer stem cells is driven by genomic instabilityin a human model of glioblastoma. Stem Cells, 2007, 25, 1478-1489.
80. Jeon, H. M.; Jin, X.; Lee, J. S.; Oh, S. Y.; Sohn, Y. W.; Park, H. J.; Joo, K. M.; Park, W. Y.; Nam, D. H.; De Pinho, R. A.; Chin, L.; Kim, H. Inhibitor of differentiation 4 drives brain tumor-initiating cellgenesis through cyclin E and notch signaling. Genes. Dev., 2008,22, 2028-2033.
81. Li, Y.; Guessous, F.; Zhang, Y.; Dipierro, C.; Kefas, B.; Johnson, E.; Marcinkiewicz, L.; Jiang, J.; Yang, Y.; Schmittgen, T. D.; Lopes, B.; Schiff, D.; Purow, B. Micro RNA-34a inhibits glioblastomagrowth by targeting multiple oncogenes. Cancer Res., 2009,69, 7569.
82. Daniel, B.; Rangarajan, A.; Mukherjee, G.; Vallikad, E.; Krishna, S. The link between integration and expression of human papillomavirustype 16 genomes and cellular changes in the evolution ofcervical intraepithelial neoplastic lesions. J. Gen. Virol., 1997, 78(Pt 5), 1095-1101.
83. Song, L. L.; Peng, Y.; Yun, J.; Rizzo, P.; Chaturvedi, V.; Weijzen, S.; Kast, W. M.; Stone, P. J.; Santos, L.; Loredo, A.; Lendahl, U.; Sonenshein, G.; Osborne, B.; Qin, J. Z.; Pannuti, A.; Nickoloff, B. J.; Miele, L. Notch-1 associates with IKKalpha and regulatesIKK activity in cervical cancer cells. Oncogene, 2008, 27, 5833-5844.
84. Zagouras, P.; Stifani, S.; Blaumueller, C. M.; Carcangiu, M. L.; rtavanis-Tsakonas, S. Alterations in Notch signaling in neoplasticlesions of the human cervix. Proc. Natl. Acad. Sci. USA, 1995, 92, 6414-6418.
85. Sun, X. M.; Wen, H. W.; Chen, C. L.; Liao, Q. P. Expression ofNotch intracellular domain in cervical cancer and effect of DAPTon cervical cancer cell. Zhonghua Fu Chan Ke Za Zhi, 2009, 44,369-373.
86. Weijzen, S.; Zlobin, A.; Braid, M.; Miele, L.; Kast, W. M. HPV16E6 and E7 oncoproteins regulate Notch-1 expression and cooperateto induce transformation. J. Cell Physiol., 2003, 194, 356-362.
87. Ramdass, B.; Maliekal, T.; Lakshmi, S.; Rehman, M.; Rema, P.; Nair, P.; Mukherjee, G.; Reddy, B. K.; Krishna, S.; Radhakrishna, P. M. Coexpression of Notch1 and NF-kappaB signaling pathwaycomponents in human cervical cancer progression. Gynecol. Oncol., 2007, 104, 352-361.
88. Wang, L.; Qin, H.; Chen, B.; Xin, X.; Li, J.; Han, H. Overexpressedactive Notch1 induces cell growth arrest of He La cervicalcarcinoma cells. Int. J. Gynecol. Cancer, 2007, 17, 1283-1292.
89. Talora, C.; Cialfi, S.; Segatto, O.; Morrone, S.; Kim, C. J.; Frati, L.; Paolo, D. G.; Gulino, A.; Screpanti, I. Constitutively active Notch1induces growth arrest of HPV-positive cervical cancer cells viaseparate signaling pathways. Exp. Cell Res., 2005, 305, 343-354.
90. Talora, C.; Sgroi, D. C.; Crum, C. P.; Dotto, G. P. Specific downmodulationof Notch1 signaling in cervical cancer cells is requiredfor sustained HPV-E6/E7 expression and late steps of malignanttransformation. Genes. Dev., 2002, 16, 2252-2263.
91. Yao, J.; Duan, L.; Fan, M.; Yuan, J.; Wu, X. Notch1 induces cellcycle arrest and apoptosis in human cervical cancer cells: involvementof nuclear factor kappa B inhibition. Int. J. Gynecol. Cancer, 2007, 17, 502-510.
92. Maliekal, T. T.; Bajaj, J.; Giri, V.; Subramanyam, D.; Krishna, S. The role of Notch signaling in human cervical cancer: implicationsfor solid tumors. Oncogene, 2008, 27, 5110-5114.
93. Li, D. W.; Wu, Q.; Peng, Z. H.; Yang, Z. R.; Wang, Y. Expressionand Significance of Notch1 and PTEN in Gastric Cancer. Ai Zheng, 2007, 26, 1183-1187.
94. Yeh, T. S.; Wu, C. W.; Hsu, K. W.; Liao, W. J.; Yang, M. C.; Li, A. F.; Wang, A. M.; Kuo, M. L.; Chi, C. W. The activated Notch1 signalpathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res., 2009, 69, 5039-5048.
95. Ji, Q.; Hao, X.; Meng, Y.; Zhang, M.; Desano, J.; Fan, D.; Xu, L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer, 2008, 8, 266.
96. Kunnimalaiyaan, M.; Chen, H. Tumor suppressor role of Notch-1signaling in neuroendocrine tumors. Oncologist, 2007, 12, 535-542.
97. D'Souza, B.; Miyamoto, A.; Weinmaster, G. The many facets ofNotch ligands. Oncogene, 2008, 27, 5148-5167.
98. Dufraine, J.; Funahashi, Y.; Kitajewski, J. Notch signaling regulatestumor angiogenesis by diverse mechanisms. Oncogene, 2008,27, 5132-5137.
99. Nefedova, Y.; Sullivan, D. M.; Bolick, S. C.; Dalton, W. S.; Gabrilovich, D. I. Inhibition of Notch signaling induces apoptosis ofmyeloma cells and enhances sensitivity to chemotherapy. Blood, 2008, 111, 2220-2229.
100. Curry, C. L.; Reed, L. L.; Golde, T. E.; Miele, L.; Nickoloff, B. J.; Foreman, KE. Gamma secretase inhibitor blocks Notch activationand induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene, 2005, 24, 6333-6344.
101. Osipo, C.; Patel, P.; Rizzo, P.; Clementz, A. G.; Hao, L.; Golde, T. E.; Miele, L. Erb B-2 inhibition activates Notch-1 and sensitizesbreast cancer cells to a gamma-secretase inhibitor. Oncogene, 2008, 27, 5019-5032.
102. Plentz, R.; Park J. S.; Rhim, A. D.; Abravanel, D.; Hezel, A. F.; Sharma, S. V.; Gurumurthy, S.; Deshpande, V.; Kenific, C.; Settleman, J.; Majumder, P. K.; Stanger, B. Z.; Bardeesy, N. Inhibition ofgamma-secretase activity inhibits tumor progression in a mousemodel of pancreatic ductal adenocarcinoma. Gastroenterology, 2009, 136, 1741-1749.
103. Zhang, Y.; Wang, Z.; Ahmed, F.; Banerjee, S.; Li, Y.; Sarkar, F. H. Down-regulation of Jagged-1 induces cell growth inhibition and Sphase arrest in prostate cancer cells. Int. J. Cancer, 2006, 119, 2071-2077.
104. Wang, Z.; Zhang, Y.; Banerjee, S.; Li, Y.; Sarkar, F. H. Notch-1down-regulation by curcumin is associated with the inhibition ofcell growth and the induction of apoptosis in pancreatic cancercells. Cancer, 2006, 106, 2503-2513.
105. Wang, Z.; Zhang, Y.; Banerjee, S.; Li, Y.; Sarkar, F. H. Inhibitionof nuclear factor kappab activity by genistein is mediated viaNotch-1 signaling pathway in pancreatic cancer cells. Int. J. Cancer, 2006, 118, 1930-1936.
106. Cecchinato, V.; Chiaramonte, R.; Nizzardo, M.; Cristofaro, B.; Basile, A.; Sherbet, G. V.; Comi, P. Resveratrol-induced apoptosisin human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem. Pharmacol., 2007, 74, 1568-1574.
107. Zhang, Z.; Wang, Y.; Yao, R.; Li, J.; Yan, Y.; La, R. M.; Lemon, W. L.; Grubbs, C. J.; Lubet, R. A.; You, M. Cancer chemopreventiveactivity of a mixture of Chinese herbs (antitumor B) in mouse lungtumor models. Oncogene, 2004, 23, 3841-3850.